Skip to main content
. 2019 Dec 4;51(1):282–290. doi: 10.1161/STROKEAHA.119.026791

Table 1.

Baseline Characteristics of Patients in MR CLEAN and the IMS III Trial According to Treatment Allocation

graphic file with name str-51-282-g002.jpg